The Plasma Derived Factor VIII Market continues to maintain its critical position within the global hemophilia A treatment landscape as healthcare systems balance the therapeutic reliability of established plasma-derived products with the growing availability of recombinant alternatives. With plasma-derived Factor VIII concentrates remaining essential for patients with inhibitors, those seeking...